Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00178126 · ClinicalTrials.gov registry record · NA

An RCT on Preventing Pressure Ulcers With Wheelchair Seat Cushions

A NA study, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
232
Enrollment target

NCT00178126: Completed NA study, sponsored by University of Pittsburgh.

NCT00178126 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 232 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00178126, a NA study, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
232 participants
Enrollment target

Study Summary

The primary aim of the proposed multi-site, randomized pressure-reducing wheelchair trial (PRWC-II) is to determine the efficacy of pressure-reducing cushions in preventing sitting-acquired pressure ulcers in the elderly, nursing home population. Positive results of the proposed trial will provide the level of evidence needed to change the standard of care to include the routine evaluation of at-risk residents for seating and positioning needs and the provision of pressure-reducing cushions as a preventive measure against sitting-acquired pressure ulcers. If our hypothesis is valid, such intervention should result in a decrease in the incidence and prevalence of sitting-acquired pressure ulcers, reduced healthcare costs, and improved quality of life.

Interventions

  • DEVICE Skin Protection Wheelchair Seat Cushion
  • DEVICE Segmented Foam Wheelchair Seat Cushion

Trial Details

FieldValue
Enrollment Target 232 participants
Start Date 2004-03
Est. Completion 2008-10
Phase NA
University of Pittsburgh

1,238 total trials

What the finished NCT00178126 record still lists

NCT00178126 is an interventional study that assigns participants to a tested intervention. The registered 232 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).

The record links to 0 conditions, and to 2 interventions - of which Skin Protection Wheelchair Seat Cushion is the first listed.

NCT00178126 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00178126 about?

NCT00178126 is a clinical study titled "An RCT on Preventing Pressure Ulcers With Wheelchair Seat Cushions". The primary aim of the proposed multi-site, randomized pressure-reducing wheelchair trial (PRWC-II) is to determine the efficacy of pressure-reducing cushions in preventing sitting-acquired pressure ulcers in the elderly, nursing home population. Positive results of the proposed trial will provide t...

What is the current status of trial NCT00178126?

This trial is currently completed. It is a NA study. The enrollment target is 232 participants. The study started on 2004-03. Estimated completion is 2008-10.

What interventions are being tested in trial NCT00178126?

The interventions under investigation include: Skin Protection Wheelchair Seat Cushion (DEVICE), Segmented Foam Wheelchair Seat Cushion (DEVICE).

Who is sponsoring clinical trial NCT00178126?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00178126's enrollment target sits among peer trials

232 463rd of 2000 higher than 1,536 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01356290 · 232 participants · Phase 2

    Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors

  • NCT04753359 · 232 participants · NA

    Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer

  • NCT04770870 · 232 participants · NA

    Post Approval Study2: Hintermann Series H3 Total Ankle Replacement System

  • NCT05948943 · 232 participants · Phase 2

    Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00178126, the US trial registry maintained by the National Library of Medicine. NCT00178126 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.